Cipla launches cut-price pirfenidone in India
This article was originally published in Scrip
Executive Summary
Cipla has launched a cut-price generic version of InterMune's idiopathic pulmonary fibrosis (IPF) drug, Esbriet (pirfenidone), on the Indian market.